07 Apr Clinical implications of molecular drug resistance testing for M. tuberculosis: a TBNET/RESIST-TB consensus statement
Posted at 13:15h
in
Authored by: Domínguez J, Boettger, Cirillo D, Cobelens F; Eisenach K, Gagneux S, Hillemann D, Horsburgh R, Molina-Moya B, Niemann S, Tortoli E, Whitelaw A, Lange C.
In: Int J Tuberc Lung Dis 2016;20:24-42.
http://www.ncbi.nlm.nih.gov/pubmed/26688526